NR546 psychopharmacology Final exam Questions With
Accurate Answers 100% Guarantee Pass 2026/2027
1. Describe the role of valproic acid in the management of bipolar disorder.
Valproic acid is primarily used for treating anxiety disorders.
Valproic acid is effective for long-term depression management.
Valproic acid is used exclusively for treating schizophrenia.
Valproic acid is used to treat acute mania and mixed mood episodes,
especially in patients with a history of multiple episodes or
substance abuse.
2. If a patient has developed tolerance to an antidepressant medication, what
might be a recommended course of action for their treatment?
Advise the patient to stop taking the medication immediately.
Consider increasing the dosage or switching to a different class of
antidepressant.
Reduce the dosage of the medication to minimize side effects.
Continue the same dosage indefinitely without changes.
3. Describe the role of the mesolimbic pathway in the context of substance use
disorders.
The mesolimbic pathway is involved in the reward system and is
crucial for the production of dopamine, which plays a significant
role in the development of substance use disorders.
The mesolimbic pathway is responsible for the metabolism of drugs in
the liver.
The mesolimbic pathway regulates serotonin levels, impacting mood
and anxiety.
, The mesolimbic pathway connects the brain to the spinal cord for
motor control.
4. Discuss how client preference can influence the effectiveness of a treatment
plan.
Client preference can complicate the prescribing process.
Client preference only affects the cost of medications.
Client preference is irrelevant to treatment outcomes.
Client preference can lead to better adherence, which enhances the
overall effectiveness of the treatment plan.
5. If a patient is prescribed a serotonergic antidepressant and begins to exhibit
symptoms such as confusion, rapid heart rate, and muscle rigidity, what
condition should be suspected?
Serotonin syndrome
Bipolar disorder
Generalized anxiety disorder
Panic attack
6. Describe how MAOIs affect neurotransmitter levels in the brain.
MAOIs block the synthesis of neurotransmitters, leading to lower
serotonin and norepinephrine levels.
MAOIs directly stimulate the release of neurotransmitters without
affecting their degradation.
MAOIs inhibit the enzyme monoamine oxidase, which increases
levels of neurotransmitters like serotonin and norepinephrine.
, MAOIs enhance the reuptake of neurotransmitters, decreasing their
levels in the brain.
7. What is the key diagnostic difference between bipolar 1 and 2?
both require at least 1 manic episode but BP2 also requires at least 1
depressive episode
BP2 requires at least 1 manic episode
both require at least 1 depressive episode but BP2 also requires at
least 1 hypomanic episode
BP1 requires at least 1 manic episode
BP1 requires both 1 manic and 1 depressive episode, BP2 requires both
1 hypomanic and 1 depressive episode
8. What term describes the reactions that occur when a substance is
discontinued suddenly?
Tolerance
Withdrawal
Dependence
Addiction
9. What is one potential metabolic side effect of using SGAs in bipolar
disorder?
Weight loss
Decreased heart rate
Increased blood sugar levels
Improved sleep quality
, 10. Which of the following is a common side effect of SSRIs?
Hypertension
Increased appetite
Sexual dysfunction
Weight gain
11. Describe the role of MAOIs in the treatment of depression based on their
mechanism of action.
MAOIs increase the levels of serotonin, norepinephrine, and
dopamine by blocking their breakdown.
MAOIs primarily target GABA to alleviate anxiety.
MAOIs enhance the reuptake of serotonin to improve mood.
MAOIs decrease the levels of neurotransmitters to reduce symptoms
of depression.
12. What is the typical duration for SSRIs side effects to subside as the body
adjusts?
2-3 days
1 month
1-2 weeks
4-5 days
13. What is serotonin syndrome?
A symptom characterized by extreme levels of mania with severe
mood swings.
A condition where a patient is prescribed an SSRI and an SNRI
Accurate Answers 100% Guarantee Pass 2026/2027
1. Describe the role of valproic acid in the management of bipolar disorder.
Valproic acid is primarily used for treating anxiety disorders.
Valproic acid is effective for long-term depression management.
Valproic acid is used exclusively for treating schizophrenia.
Valproic acid is used to treat acute mania and mixed mood episodes,
especially in patients with a history of multiple episodes or
substance abuse.
2. If a patient has developed tolerance to an antidepressant medication, what
might be a recommended course of action for their treatment?
Advise the patient to stop taking the medication immediately.
Consider increasing the dosage or switching to a different class of
antidepressant.
Reduce the dosage of the medication to minimize side effects.
Continue the same dosage indefinitely without changes.
3. Describe the role of the mesolimbic pathway in the context of substance use
disorders.
The mesolimbic pathway is involved in the reward system and is
crucial for the production of dopamine, which plays a significant
role in the development of substance use disorders.
The mesolimbic pathway is responsible for the metabolism of drugs in
the liver.
The mesolimbic pathway regulates serotonin levels, impacting mood
and anxiety.
, The mesolimbic pathway connects the brain to the spinal cord for
motor control.
4. Discuss how client preference can influence the effectiveness of a treatment
plan.
Client preference can complicate the prescribing process.
Client preference only affects the cost of medications.
Client preference is irrelevant to treatment outcomes.
Client preference can lead to better adherence, which enhances the
overall effectiveness of the treatment plan.
5. If a patient is prescribed a serotonergic antidepressant and begins to exhibit
symptoms such as confusion, rapid heart rate, and muscle rigidity, what
condition should be suspected?
Serotonin syndrome
Bipolar disorder
Generalized anxiety disorder
Panic attack
6. Describe how MAOIs affect neurotransmitter levels in the brain.
MAOIs block the synthesis of neurotransmitters, leading to lower
serotonin and norepinephrine levels.
MAOIs directly stimulate the release of neurotransmitters without
affecting their degradation.
MAOIs inhibit the enzyme monoamine oxidase, which increases
levels of neurotransmitters like serotonin and norepinephrine.
, MAOIs enhance the reuptake of neurotransmitters, decreasing their
levels in the brain.
7. What is the key diagnostic difference between bipolar 1 and 2?
both require at least 1 manic episode but BP2 also requires at least 1
depressive episode
BP2 requires at least 1 manic episode
both require at least 1 depressive episode but BP2 also requires at
least 1 hypomanic episode
BP1 requires at least 1 manic episode
BP1 requires both 1 manic and 1 depressive episode, BP2 requires both
1 hypomanic and 1 depressive episode
8. What term describes the reactions that occur when a substance is
discontinued suddenly?
Tolerance
Withdrawal
Dependence
Addiction
9. What is one potential metabolic side effect of using SGAs in bipolar
disorder?
Weight loss
Decreased heart rate
Increased blood sugar levels
Improved sleep quality
, 10. Which of the following is a common side effect of SSRIs?
Hypertension
Increased appetite
Sexual dysfunction
Weight gain
11. Describe the role of MAOIs in the treatment of depression based on their
mechanism of action.
MAOIs increase the levels of serotonin, norepinephrine, and
dopamine by blocking their breakdown.
MAOIs primarily target GABA to alleviate anxiety.
MAOIs enhance the reuptake of serotonin to improve mood.
MAOIs decrease the levels of neurotransmitters to reduce symptoms
of depression.
12. What is the typical duration for SSRIs side effects to subside as the body
adjusts?
2-3 days
1 month
1-2 weeks
4-5 days
13. What is serotonin syndrome?
A symptom characterized by extreme levels of mania with severe
mood swings.
A condition where a patient is prescribed an SSRI and an SNRI
